ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 824 filers reported holding ISHARES TR in Q3 2022. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,050,975 | -5.6% | 188,494 | -2.0% | 0.02% | -5.0% |
| Q2 2023 | $24,414,620 | -7.0% | 192,302 | -5.3% | 0.02% | -13.0% |
| Q1 2023 | $26,241,569 | +1.3% | 203,171 | +2.9% | 0.02% | -4.2% |
| Q4 2022 | $25,913,091 | +23.4% | 197,372 | +9.9% | 0.02% | +14.3% |
| Q3 2022 | $20,996,000 | +16.4% | 179,515 | +17.1% | 0.02% | +16.7% |
| Q2 2022 | $18,032,000 | -19.0% | 153,291 | -10.2% | 0.02% | -5.3% |
| Q1 2022 | $22,254,000 | -20.1% | 170,793 | -6.4% | 0.02% | -13.6% |
| Q4 2021 | $27,852,000 | -6.6% | 182,490 | -1.1% | 0.02% | -18.5% |
| Q3 2021 | $29,822,000 | +6.1% | 184,443 | +7.4% | 0.03% | +3.8% |
| Q2 2021 | $28,118,000 | -0.5% | 171,813 | -8.4% | 0.03% | -10.3% |
| Q1 2021 | $28,255,000 | -14.3% | 187,659 | -13.7% | 0.03% | -19.4% |
| Q4 2020 | $32,957,000 | +22.4% | 217,545 | +9.4% | 0.04% | +5.9% |
| Q3 2020 | $26,923,000 | -5.6% | 198,821 | -4.7% | 0.03% | -10.5% |
| Q2 2020 | $28,510,000 | +86.0% | 208,574 | +46.6% | 0.04% | +58.3% |
| Q1 2020 | $15,330,000 | -26.2% | 142,285 | -17.4% | 0.02% | -7.7% |
| Q4 2019 | $20,770,000 | +38.0% | 172,346 | +14.0% | 0.03% | +23.8% |
| Q3 2019 | $15,049,000 | -26.7% | 151,244 | -19.6% | 0.02% | -30.0% |
| Q2 2019 | $20,522,000 | -10.6% | 188,101 | -8.3% | 0.03% | -14.3% |
| Q1 2019 | $22,944,000 | +14.2% | 205,215 | -1.5% | 0.04% | 0.0% |
| Q4 2018 | $20,091,000 | -36.9% | 208,335 | -20.2% | 0.04% | -28.6% |
| Q3 2018 | $31,848,000 | +23.8% | 261,163 | +11.5% | 0.05% | +14.0% |
| Q2 2018 | $25,726,000 | -15.3% | 234,242 | -17.6% | 0.04% | -20.4% |
| Q1 2018 | $30,358,000 | +2.0% | 284,398 | +2.1% | 0.05% | -1.8% |
| Q4 2017 | $29,750,000 | +6.0% | 278,618 | +231.3% | 0.06% | -1.8% |
| Q3 2017 | $28,060,000 | +16.8% | 84,105 | +8.6% | 0.06% | +7.7% |
| Q2 2017 | $24,026,000 | +32.5% | 77,479 | +25.3% | 0.05% | +23.8% |
| Q1 2017 | $18,136,000 | -31.8% | 61,835 | -38.3% | 0.04% | -38.2% |
| Q4 2016 | $26,608,000 | +8.5% | 100,260 | +18.4% | 0.07% | +1.5% |
| Q3 2016 | $24,519,000 | +112.4% | 84,703 | +88.8% | 0.07% | +86.1% |
| Q2 2016 | $11,546,000 | +54.0% | 44,866 | +56.1% | 0.04% | +44.0% |
| Q1 2016 | $7,497,000 | -57.6% | 28,745 | -45.1% | 0.02% | -60.3% |
| Q4 2015 | $17,700,000 | +3.4% | 52,313 | -7.3% | 0.06% | -10.0% |
| Q3 2015 | $17,117,000 | -23.5% | 56,426 | -6.9% | 0.07% | -18.6% |
| Q2 2015 | $22,374,000 | +8.0% | 60,635 | +0.5% | 0.09% | -5.5% |
| Q1 2015 | $20,720,000 | +34.5% | 60,333 | +18.8% | 0.09% | +21.3% |
| Q4 2014 | $15,407,000 | +125.9% | 50,789 | +103.7% | 0.08% | +92.3% |
| Q3 2014 | $6,821,000 | -8.2% | 24,928 | -13.8% | 0.04% | -15.2% |
| Q2 2014 | $7,433,000 | +21.6% | 28,918 | +11.9% | 0.05% | +9.5% |
| Q1 2014 | $6,112,000 | +28.6% | 25,853 | +23.5% | 0.04% | +16.7% |
| Q4 2013 | $4,754,000 | +15.4% | 20,935 | +6.5% | 0.04% | 0.0% |
| Q3 2013 | $4,120,000 | +40.9% | 19,655 | +16.9% | 0.04% | +28.6% |
| Q2 2013 | $2,925,000 | – | 16,819 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |